Delivery Order SPE2DB20D3101-SPE2DB25FREV7
Award Date
3/19/25
Potential Completion Date
3/20/25
Potential Value
$2.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,667.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566961838 - NALOXONE HCL 4 MG NASAL SPRAY 2S, a critical medication used for the treatment of opioid overdose. The contract is a Delivery Order with a Firm Fixed Price pricing type, and an ultimate completion date of January 17, 2025. Amerisourcebergen holds a...
This federal contract award, valued at $1,755.41, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NALOXONE HCL 4 MG NASAL SPRAY 2S, a critical medication used in the treatment of opioid overdose. The contract has an ultimate completion date of October 30, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $7,744.93, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,564,861,499 units of Naloxone HCL 4 mg Nasal Spray, a critical medication used to treat opioid overdoses. The contract has an ultimate completion date of June 11, 2024 and is a firm fixed-price delivery order. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,355.00 fixed-price delivery order is for the supply of NALOXONE HCL 4 MG NASAL SPRAY 2S, a critical medication used for the treatment of opioid overdose. The contract has an ultimate completion date of February 21, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,524.80 firm fixed price delivery order is for the supply of 4 mg Naloxone HCl nasal spray, a critical medication used to treat opioid overdose. The contract has an ultimate completion date of January 29, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,632,850 units of NALOXONE HCL 4 MG NASAL SPRAY 2S. The fixed-price delivery order, valued at $1,217.04, has a period of performance through March 20, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the provision of 4,561,027,452 units of Naloxone HCL 4 mg Nasal Spray, a critical medication used to treat opioid overdoses. The award, valued at $2,931.70, has a firm fixed-price structure and an ultimate completion date of May 24, 2023. This contract is not set aside for any specific business type....
This federal contract award, valued at $4,649.90, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,421,527 units of Naloxone Hydrochloride 4 mg Nasal Spray, a critical medication used to reverse opioid overdoses. This is a firm-fixed price delivery order contract with a completion date of March 3, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is a Delivery Order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,039,734 units of Naloxone HCL 4 mg Nasal Spray, a critical medication used to treat opioid overdoses. The contract has a Firm Fixed Price of $2,400.09 and a period of performance through January 27, 2025. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award, valued at $7,194.83, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,557,108,798 units of 4 mg Naloxone HCL nasal spray, a medication used to treat opioid overdose. The contract has a completion date of May 5, 2022 and utilizes a firm fixed price pricing type. Amerisourcebergen Drug Corp is a subsidiary of the parent company...